These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6424810)

  • 21. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial.
    Kim IK; Phrampus E; Venkataraman S; Pitetti R; Saville A; Corcoran T; Gracely E; Funt N; Thompson A
    Pediatrics; 2005 Nov; 116(5):1127-33. PubMed ID: 16263999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled powder and aerosol salbutamol in metacholine-induced bronchial obstruction.
    Lahdensuo A; Sovijärvi A; Muittari A
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():515-7. PubMed ID: 6352312
    [No Abstract]   [Full Text] [Related]  

  • 23. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group.
    Gross N; Tashkin D; Miller R; Oren J; Coleman W; Linberg S
    Respiration; 1998; 65(5):354-62. PubMed ID: 9782217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro comparison of 4 large-volume nebulizers in 8 hours of continuous nebulization.
    Berlinski A; Willis JR; Leisenring T
    Respir Care; 2010 Dec; 55(12):1671-9. PubMed ID: 21122175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With Double-Limb Circuit.
    Velasco J; Berlinski A
    Respir Care; 2018 Feb; 63(2):141-146. PubMed ID: 29114011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breath-actuated nebulizer versus small-volume nebulizer: efficacy, safety, and satisfaction.
    Ari A; Fink JB
    Respir Care; 2012 Aug; 57(8):1351-3. PubMed ID: 22867645
    [No Abstract]   [Full Text] [Related]  

  • 29. Performance Comparisons of Jet and Mesh Nebulizers Using Different Interfaces in Simulated Spontaneously Breathing Adults and Children.
    Ari A; de Andrade AD; Sheard M; AlHamad B; Fink JB
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):281-9. PubMed ID: 25493535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is driving oxygen flow rate clinically important for nebulizer therapy in patients with COPD?
    Charoenratanakul S; Borrirukwanit K; Lekuthai S; Satayawiwat W; Dejsomritrutai W
    J Med Assoc Thai; 1995 Dec; 78(12):670-6. PubMed ID: 8868011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhalation therapy with selective beta 2-sympathomimetic drugs. Effect of pirbuterol administered via the Autohaler and salbutamol administered via the Diskhaler in obstructive respiratory tract disease].
    Hoffarth HP; Freyberger H; Völkl KP; Ulmer WT
    Fortschr Med; 1990 Mar; 108(8):162-4. PubMed ID: 2186991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDA approves new inhaler without CFCs.
    FDA Consum; 2001; 35(4):3. PubMed ID: 11692883
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intrapulmonary gas exchange and right-left shunt in chronic obstructive lung diseases].
    Redhammer R; Kratochvílová E; Janok J
    Vnitr Lek; 1980; 26(12):1157-64. PubMed ID: 6782751
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of Heliox on the output and particle-size distribution of salbutamol using jet and vibrating mesh nebulizers.
    O'Callaghan C; White J; Jackson J; Crosby D; Dougill B; Bland H
    J Aerosol Med; 2007; 20(4):434-44. PubMed ID: 18158716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Air or oxygen as driving gas for nebulised salbutamol.
    Gleeson JG; Green S; Price JF
    Arch Dis Child; 1988 Aug; 63(8):900-4. PubMed ID: 3046513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Heat Moisture Exchanger on Aerosol Drug Delivery and Airway Resistance in Simulated Ventilator-Dependent Adults Using Jet and Mesh Nebulizers.
    Ari A; Dang T; Al Enazi FH; Alqahtani MM; Alkhathami A; Qoutah R; Almamary AS; Fink JB
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):42-48. PubMed ID: 28829202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interpreting arterial blood gas values.
    Pfister S; Bullas JB
    Crit Care Nurse; 1986; 6(4):9-14. PubMed ID: 3089689
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
    Sorbini CA; Todisco T; Boschetti E
    Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
    [No Abstract]   [Full Text] [Related]  

  • 40. Heliox-driven albuterol nebulization for asthma exacerbations: an overview.
    Kim IK; Saville AL; Sikes KL; Corcoran TE
    Respir Care; 2006 Jun; 51(6):613-8. PubMed ID: 16723038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.